Clinical Trial Update: Asciminib in HER2+ Breast Cancer Brain Metastases [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update indicates Asciminib is being studied in HER2-positive metastatic breast cancer with brain metastases in Phase 1/Phase 2, currently not r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer

Drugs mentioned

• Asciminib (asciminib)

Snippet

Sponsor: Duke University | Conditions: HER2+ Metastatic Breast Cancer | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING